Navigation Links


number at medicine technology

Point of Care Strep Tests Speed Treatment, Lower Costs

...iminating the need for test tubes and reducing the number of steps. This test exhibits a 93 percent accuracy compared to plate culture. The QuickVue In-Line Strep A Test from Quidel Corporation, San Diego, Calif., also allows for the rapid detection of group A streptococcal antigen directly from patien...

Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies

...levated white blood cell count, an increased total number of lymphocytes and greater than 10 percent atypical lymphocytes. In keeping with the rapid proliferation of point-of-care diagnostic kits and devices, several products have now been CLIA-waived by the Centers for Disease Control and Prevention (CDC)....

Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse

...assay can be used for large batches of samples. A number of single use devices incorporating immunoassays and designed to be used outside of the traditional laboratory have become available. These devices require FDA approval to be sold in the United States, and their use in non-medical environments such a...

Lab Automation Networks Proliferating

...ave stimulated decisions to automate an increasing number of pre-analytic functions or distinct workcell areas. Several hundred clinical labs worldwide have even taken the giant stride of converting to total laboratory automation, based on strong evidence that automation not only heightens profitability but...

The Past, Present and Future of HLA Typing

... average turnaround time, required resolution, and number of average samples per day. For those laboratories with access to Sequencers, it may be the most sensitive, specific and cost effective option to sequence certain HLA loci directly. And as more and more diseases are linked to specific HLA polymorp...

New Assays to Detect Disseminated Fungal Infections

... to be discovered only at autopsy. Fortunately, a number of new assays offer solutions to these problems. F...ent of the fungal cell wall. Glucan is found in a number of medically important fungi such as Candida , Aspergillus , Fusarium, Acremonium, and Saccharo...

Testing for Human Papillomavirus

...roximately 50 anogenital HPVs, there are a limited number of high and intermediate risk types detected in anogenital cancer biopsy specimens. Worldwide, HPV has been associated with 99.7% of squamous cell cancers of the cervix. Most genital HPV infections in women produce transient squamous cell abnormalit...

Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.

...nt CYP subtypes. The first, CYP2D6, metabolizes a number of medications, including antidepressants, anti-ps...mpanies such as Nanogen also continue to develop a number of microarray-based tools. Together, these advances will make tailored drug therapy a reality, and ...

Appendicitis: Evolving Tools to Diagnose a Classic Disease

...ule out appendicitis definitively. Fortunately, a number of laboratory and imaging modalities, some new and sophisticated, can improve levels of clinical confidence. Ideally, these tools should provide optimal positive predictive value to facilitate early appendectomy, all in an effort to reduce mortali...

Avian (Bird) Flu: Is There a Role for Rapid Tests?

...suspected. These guidelines (link below) convey a number of important points. Overall, information is limi...be tested on multiple days. The FDA has approved a number of rapid tests for influenza A. In theory, any of these products can detect the H5N1 subtype, but i...

Managing Preanalytical Processes for Patient Safety

...vice indicates the collection details, such as the number and types of tubes, and order of draws. The phlebo...specimen are around 75 cents. Multiply that by the number of specimens that require re-labeling, and the cost can be astronomical. The opportunity for error i...

Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal

...nhealthy distribution of particles. Accordingly, a number of tests have been developed that focus on lipid particle size and density. The Lipoprint (Quantimetrix) was designed to do just that. The test uses a gel electrophoresis method to examine lipoprotein subfractions, including 12 cholesterol paramete...

Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control

...portance. The study showed that lowering the HbA1c number can potentially reduce the development of complications and that lowering HbA1c levels by any amount improves a person's chances of staying healthy. All HbA1c tests are not the same, but there is an ongoing international effort to standardize them by...

Hematology Analyzers Simple, Sophisticated Technology Serving All Patients

...ineer was tasked with counting plankton in a large number of seawater samples. He devised a dual chamber con...based upon known cell-surface markers. Because the number of cells counted by an automated system is many times greater than the number countable by eye in a ...

Rapid HIV Testing Increases Possibility of Treatment

...n HIV/AIDS) and the World Health Organization, the number of people living with HIV globally reached an esti...and unaware of their status. To address the large number of people who are unaware of their status, considerable progress has occurred in prompt, definitive ...

Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing

... such as blood transfusions, is based on a certain number of laboratory results. Transfusion strategies (red blood cells and platelet concentrates) rely on almost daily CBC monitoring in addition to screening for irregular agglutinins in transfusion cases or measuring markers of other vital functions in ch...

Optimizing Quality Control Data Management

...s to improve analytical performance and reduce the number of false rejections: Imprecision based upon Biological Variation and State of the Art help the laboratory confine imprecision within defined limits. Medical Relevance can be used to distinguish between statistical error and a medically important ch...

Urinalysis Analyzers: Large Capabilities in Every Size Device

...with the integrated keypad, along with a secondary number that can be used sequentially or adjusted to be the instrument, location or operator identification. List price for the PocketChem is $625. Hypoguard USA, Inc., Edina, Minn., a division of British firm Medisys, manufactures the DiaScreen 50 Urine Che...

Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs

...regulatory process, changes in markettrends, and a number of other factors and risks described from timeto time in the Company's filings with the Securities and ExchangeCommission. Contact RBC Life Sciences, Inc. Steve Brown, CFO, 972-893 4000 <a target="_blank" href="mailto:sbrown@rbcls.com">stev...

Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology

...hey used state populations to calculate theaverage number of prescriptions written per person. Researcher...rescribed per 1000 persons in the U.S. The highest number ofprescriptions per 1000 persons was in Massachusetts with 11.8.Hawaii had the lowest with 2.7 presc...

Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial

...e forward looking statements that are subject to a number ofrisks and uncertainties that could cause actual results to differmaterially from results, performance or achievements expressed orimplied by such statements. These risks and uncertainties may beassociated with product discovery and development, inc...

Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent

... 1 IU/dL withprophylactic therapy may decrease the number of bleeding episodes,particularly in children. "U...ins and coauthors were able to estimate the median number ofhours per week spent below the 1 IU/dL trough level for eachpopulation, 19.7 hours and 16.5 hours ...

Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis

...rf stockexchange under the symbol B8F and the ISIN number DE0006046113.<a target="_blank" href="http://www.biofrontera.com/">http://www.biofrontera.com/ This press release contains forward-looking statements based onthe currently held beliefs and assumptions of the management ofBiofrontera AG, whi...

Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy

...s have been shown to be very active clinicallyin a number of tumor types. However, they are usually associat... includes forward-looking statements thatinvolve a number of risks and uncertainties, the outcome of whichcould materially and/or adversely affect actual futu...

Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society

...r injected drugs and fluids. TheCompany also has a number of different enzymes in its portfoliothat are targeting significant areas of unmet need. Safe Harbor Statement In addition to historical information, the statements set forthabove include forward-looking statements (including, withoutlimitation, st...

Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis

... or 70%) in certain RA symptoms and measures the number of tender and swollen joints, pain, patient's and physician's global assessments and certain laboratory markers. An ACR70 response is considered exceptional and represents a significant improvement in a patient's condition...

Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimer's Disease

...zheimer's disease still remains unknown, a growing number ofresearchers are indicating that plaque formation and accumulationmay play a role. The study was conducted by Samaritan's collaboratingresearchers, including Dr. Laurent Lecanu and Dr. VassiliosPapadopoulos. Abstract: <a target="_blank" hre...

Protox Announces Positive Clinical Data from Prostate Cancer Study

...n in study patients, as well as a reduction in the number of positive biopsies after treatment.Second, there...er the reservationnumber 21240373 followed by the number sign. A live audio webcastof the conference call will be available at <a target="_blank" href='...

SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

...ematologicalmalignancies. SuperGen is developing a number of therapeuticanticancer products focused on kinase and cell signaling inhibitorsand DNA methyltransferase inhibitors. For more information aboutSuperGen, please visit <a target="_blank" href="http://www.supergen.com/">http://www.supergen.com...

Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

...orationwith leading pharmaceutical companies, in a number of diseaseareas, including epilepsy; pain; inflamm... contains forward-looking statements thatinvolve a number of risks and uncertainties. For this purpose, anystatements contained herein that are not statements...

International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis

...nstance, VTE prophylaxis has beenidentified as the number #1 strategy to improve patient safety inthe hospit...as the scientificcoordinating center for a growing number of national andinternational outcomes registries. COR's responsibilities includemaintaining patient ...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

...e world's leading pharmaceuticalcompanies, ranking number one in Europe. Backed by a world-classR&D organisation, sanofi-aventis is developing leadingpositions in seven major therapeutic areas: cardiovascular,thrombosis, oncology, metabolic diseases, central nervous system,internal medicine and vaccines...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

...current therapies andhelp to treat the significant number of under- and un-treatedpatients at risk for life-threatening thrombotic events." The trade name of rivaroxaban is expected to be Xarelto(R),pending health authority approval. Results from other phase III trials in the RECORD program,RECORD1 and RE...

Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

...of vitamin D,which has been clinically tested in a number of solid tumortypes. Further information about Co... current information andexpectations and involve a number of risks and uncertainties.Actual events or results may differ materially from those projectedin any...

TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

...risk for the disease.Over the next five years, the number of people suffering fromosteoporosis is expected to reach 52 million, creating a $10.4billion market by 2011. About the ViaDerm System TransPharma's ViaDerm drug delivery system incorporates ahandheld electronic control unit combined with a drug pa...

Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings

...gement's current expectations and are subject to a number offactors and uncertainties, which could cause actual results todiffer materially from those described in such statements. Wecaution investors that actual results or business conditions maydiffer materially from those projected or suggested inforward...

Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

...ach has the potential to treat CDAD and reduce the number ofdisease recurrences, resulting in improved quality of life for thepatient and significant savings to the healthcare system. About the PACT Study The PACT study, which involved more than 1,100 patients atapproximately 300 sites in North America, E...

New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV

...e Lancet article.Kaiser Permanente had the highest number of enrollees in the studyfrom the United States. Dr. Towner said that the ongoing 'DUET-2' trial -- large,randomized, and placebo controlled -- is the pivotal registrationand efficacy trial for TMC125 (it is in a class of HIV drugs callednon-nucleos...

DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC

...ilar expressions. Thesestatements are subject to a number of risks, uncertainties andother factors that could cause actual events or results in futureperiods to differ materially from what is expressed in, or impliedby, these statements. DOR cannot assure you that it will be able tosuccessfully develop or c...

Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer

... the hormone progesterone wasshown to increase the number of growing tumors. Conversely, theadministration o... in the United States and results in a significant number ofhysterectomies each year. Proellex has recently completed asix-month European Phase 1/2 study for ...

Avexa's Apricitabine Clinical Trial Update

...apricitabine is welltolerated in HIV patients. The number of patients requesting toenter the extension study after the 48 week trial to continuetreatment with apricitabine is an indicator of the important rolethat apricitabine will play in the management of HIV.Apricitabine's clinical development remains on...

Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience

...ent treatment optionsare insufficient. Suven has a number of programs in each of theseareas, focusing on nov...se may be forward-lookingstatements that involve a number of risks and uncertainties.Although Suven attempts to be accurate in making theseforward-looking sta...

Genzyme Announces Results of Clinical Trial of Hylastan

...d the benefits ofviscosupplementation to a broader number of patients. Genzyme's development program also includes Synvisc-One(TM), aninvestigational combined-dose regimen of Synvisc(R) (hylan G-F 20)provided in a single injection, which the company is currentlyseeking to market in the United States and Eu...

Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting

...rities LitigationReform Act of 1995 that involve a number of risks anduncertainties. There can be no assurance that such statements willprove to be accurate and the actual results and future events coulddiffer materially from management's current expectations. Theconduct of clinical trials and the developme...

Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics

...xic side effects in normal cells. Theyexpanded the number of mesenchymal stem cells in the laboratory andthen used a retrovirus vector to insert the gene cytosine deaminaseinto the cell. This gene can convert a less toxic drug, 5-fluorocytosine (5-FC), to 5-FU inside the stem cells, andthe chemotherapy can ...

Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia

...ge at onsetof menses, age at birth of first child, number of previous breastbiopsies, presence of atypia, and number of close relatives withbreast cancer. While the Mayo Clinic study found that family history did n...

Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections

... patients is Tobramycin but there are anincreasing number of Tobramycin resistant strains of Pseudomonas.The...mpliance with the study protocol, and a sufficient number ofpatients completing the studies; the ability of the company tocommercialize its planned products; ...

Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

...ble in themajor markets. However, entacapone has a number of drawbacks,namely a short half-life, relatively ...series has beenachieved by CeNeS scientists, and a number of discrete chemicalseries without the nitrocatechol group have been identified. TheCOMT inhibitor p...

DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC

...ilar expressions. Thesestatements are subject to a number of risks, uncertainties andother factors that could cause actual events or results in futureperiods to differ materially from what is expressed in, or impliedby, these statements. DOR cannot assure you that it will be able tosuccessfully develop or c...

Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29

...tinent, percent of heavydrinking days, and average number of drinks per day. ALKS 29 wasgenerally well toler...ays abstinent, percent of heavy drinking days, and number ofdrinks per day. Heavy drinking is defined as five or more drinksper day for men and four or more d...

Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine

...erially from those projected hereinand depend on a number of factors, including the uncertaintiesrelated to the regulatory process and the commercialization of theCompany's products, if they are approved, specifically, theadoption of such products by physicians and patients.. Investorsshould consult the Com...

European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGene's Cancer-Killing Virus in Press Conference

...om our trialin a press conference. Considering the number of studies presentedon Europe's largest cancer congress, this emphasizes the innovationand the potential of this approach to fight cancer." Journalists interested in joining the press conference pleasecontact <a target="_blank" href="mailto:medi...

Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstrom's Macroglobulinemia

...ass, oralanticancer agent that modulates AKT and a number of other keysignal transduction pathways, includin...1, may beforward-looking statements that involve a number of risks anduncertainties. For those statements, we claim the protection of thesafe harbor for forwa...

The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients

...8 percent responserate in relapsed patients. "The number of options available to treat myeloma patients todayis growing with positive results from mature studies, as well aspreliminary results from smaller trials," said Brian G.M. Durie,M.D. chairman and co- founder of the IMF. "What we are learningfrom us...

CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP

...sses andelevation of CRP has been established in a number ofimmuno-inflammatory diseases, including RA. Conference Call Information CombinatoRx management will host a conference call to discussthese results at 8:30 a.m. ET on Thursday, June 28, 2007. To accessthe call, please dial 800.591.6930 (domestic) ...

Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop

...tements. Such forward-looking statements involve a number ofrisks and uncertainties and investors are cautio....In particular, Cytogen's business is subject to a number ofsignificant risks, which include, but are not limited to: the riskof obtaining the necessary regul...

CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS

...cebo-controlled and is planned to include a larger number ofvolunteers, treated for a longer period of time with a four-foldhigher dose than that used in the open-label clinical trial." The open-label extension clinical trial was initiated inFebruary 2006 as ALS volunteers completing CytRx'splacebo-control...

Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone

...0.0001 vs. placebo+metformin). In this study, the number of subjects with investigator-reportedhypoglycemia, with or without confirmation, were: 9 onplacebo+metformin, and 15, 10 and 7, for 2.5 mg, 5 mg, and 10 mg onsaxagliptin+metformin, respectively. There was one subject withconfirmed hypoglycemia in ea...

Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone

....0001 vs. placebo+metformin). In this study, the number of subjects with investigator-reportedhypoglycemia, with or without confirmation, were: 9 onplacebo+metformin, and 15, 10 and 7, for 2.5 mg, 5 mg, and 10 mg onsaxagliptin+metformin, respectively. There was one subject withconfirmed hypoglycemia in e...

Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease

...ffect the aging process in mammalsand increase the number and function of mitochondria. According to the ...ur pipeline of SIRT1 modulators designedto treat a number of diseases of aging such as metabolic andmitochondrial disorders, and now neurological disorders." ...
Other Contentsgreengreengreengreengreengreengreengreenbluebluebluebluebluebluebluebluebrachialbrachialbractbreedbreedbreedbreedbranchbranchbranchbranchbranchbranchbranchbronchibronchi
(Date:8/20/2008)...hat an interdisciplinary and coordinated research ...ence and influencing policy, a group of experts ha...ing of how mercury moves through the marine ecosys...outh,s Toxic Metals Research Program convened the ...lators, and public health experts in November 2006...
(Date:8/20/2008)...people from heart attacks. But to do that they hav...y. , Earlier this year, a team led by William Mai...ommercial radio transmitter could be used to modif...cientist, 22 March, p 23). Doctors normally use t...evice, but a malicious hacker could reprogram the ...
(Date:8/20/2008)...s called polyketals and their derivatives may impr...cute lung injury, acute liver failure and inflamma...nd snips of ribonucleic acid to disease locations ...developed are simply a vehicle to get the drugs in...ossible," said Niren Murthy, assistant professor i...
(Date:8/20/2008)...Institute (NHGRI), part of the National Institutes...ion in grants to develop innovative sequencing tec...ence a person,s DNA as a routine part of biomedica...omprehensively sequence any person,s genome is the... personalized medicine where healthcare providers ...
Breaking Biology News(10 mins):Dartmouth workshop sets research agenda for environmental mercury 2How to stop a new type of heart attack 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 2NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 5Environmental stress probed in cardiovascular disease diabetes 588 1Environmental stress probed in cardiovascular disease diabetes 588 2Study details regulation of vital tumor suppressor gene p53 586 1Study details regulation of vital tumor suppressor gene p53 586 2Shipcom Partners With DOKUMENTA for METROs Future Store Initiative 581 1Shipcom Partners With DOKUMENTA for METROs Future Store Initiative 581 2Shipcom Partners With DOKUMENTA for METROs Future Store Initiative 581 3Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding 576 1Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding 576 2Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding 576 3
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
Other TagsBuckleCablesTriageOrthopaedicOther Tagsentirely 2entirely 3entirely 4entirely 5entirely 6entirely 7entirely 8entirely 9entirely 10recent 2recent 3recent 4recent 5recent 6recent 7recent 8recent 9recent 10respond 2respond 3respond 4respond 5respond 6respond 7respond 8respond 9respond 10detect 2detect 3detect 4detect 5detect 6detect 7detect 8detect 9detect 10insects 2insects 3insects 4insects 5insects 6insects 7insects 8allows 2allows 3allows 4allows 5allows 6allows 7allows 8allows 9allows 10